- Home
- MAZE vs ODV Comparison
MAZE vs ODV Comparison
Compare MAZE & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAZE
- ODV
- Stock Information
- Founded
- MAZE 2018
- ODV 2005
- Country
- MAZE United States
- ODV Canada
- Employees
- MAZE N/A
- ODV N/A
- Industry
- MAZE
- ODV Precious Metals
- Sector
- MAZE
- ODV Basic Materials
- Exchange
- MAZE NYSE
- ODV Nasdaq
- Market Cap
- MAZE 367.0M
- ODV 302.0M
- IPO Year
- MAZE 2025
- ODV N/A
- Fundamental
- Price
- MAZE $16.93
- ODV $2.44
- Analyst Decision
- MAZE Strong Buy
- ODV
- Analyst Count
- MAZE 4
- ODV 0
- Target Price
- MAZE $23.50
- ODV N/A
- AVG Volume (30 Days)
- MAZE 129.8K
- ODV 599.3K
- Earning Date
- MAZE 08-14-2025
- ODV 08-11-2025
- Dividend Yield
- MAZE N/A
- ODV N/A
- EPS Growth
- MAZE N/A
- ODV N/A
- EPS
- MAZE 0.34
- ODV N/A
- Revenue
- MAZE $167,500,000.00
- ODV $1,943,159.00
- Revenue This Year
- MAZE N/A
- ODV $539.98
- Revenue Next Year
- MAZE N/A
- ODV $397.65
- P/E Ratio
- MAZE $53.00
- ODV N/A
- Revenue Growth
- MAZE N/A
- ODV N/A
- 52 Week Low
- MAZE $6.71
- ODV $1.16
- 52 Week High
- MAZE $18.50
- ODV $2.75
- Technical
- Relative Strength Index (RSI)
- MAZE N/A
- ODV 60.16
- Support Level
- MAZE N/A
- ODV $2.46
- Resistance Level
- MAZE N/A
- ODV $2.70
- Average True Range (ATR)
- MAZE 0.00
- ODV 0.13
- MACD
- MAZE 0.00
- ODV 0.02
- Stochastic Oscillator
- MAZE 0.00
- ODV 58.87
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.